Skip to content
CompanyNewsHQ

CompanyNewsHQ

CompanyNewsHQ

  • Industry
    • Accountancy
    • Aerospace & Defense
    • Airline
    • Automotive
    • Chemicals
    • Construction
    • Energy
    • Facilities Management
    • Fashion
    • Finance and Utilities
    • Food and Drink
    • Insurance
    • Legal
    • Logistics
    • M&A News
    • Media & Entertainment
    • Medical Device
    • Parcels
    • Pharmaceutical
    • Private Equity
    • Retail
    • Technology
    • Telecoms
    • Travel
  • Companies A-Z
  • Submit A Press Release
  • Subscribe
  • Advertising
  • Market Reports
  • Contact Us

Amgen

Pharmaceutical Company News 

Acclaimed Makeup Artist Allan Avendaño Opens Up About Personal Skin Condition: Provides INSIDE LOOK At Life With Plaque Psoriasis

June 15, 2021 Michael Crowe Amgen

THOUSAND OAKS, Calif., June 15, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) and Otezla® (apremilast) have partnered with Allan Avendaño, makeup artist to

Read more
Pharmaceutical Company News 

Amgen To Present At The Goldman Sachs 42nd Annual Global Healthcare Conference

June 4, 2021 Michael Crowe Amgen

THOUSAND OAKS, Calif., June 4, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 42nd Annual Global Healthcare Conference

Read more
Pharmaceutical Company News 

Results From Phase 2 CodeBreaK 100 Show LUMAKRAS™ (sotorasib) Is The First And Only KRAS G12C Inhibitor With Overall Survival Data

June 4, 2021 Michael Crowe Amgen

THOUSAND OAKS, Calif., June 4, 2021 /PRNewswire/ — Amgen (NASDAQ: AMGN) today presented data on overall survival, a secondary endpoint, from

Read more
Pharmaceutical Company News 

Phase 2 Fight Trial Continues To Show Improved Overall Survival With Bemarituzumab Plus Chemotherapy In Patients With FGFR2b+ Gastric And Gastroesophageal Cancers

June 4, 2021 Michael Crowe Amgen

THOUSAND OAKS, Calif., June 4, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced updated results for investigational bemarituzumab in combination with chemotherapy

Read more
Pharmaceutical Company News 

Amgen to Webcast Investor Meeting at ASCO 2021

June 1, 2021 Michael Crowe Amgen

THOUSAND OAKS, Calif., June 1, 2021 /PRNewswire/ — Amgen (NASDAQ: AMGN) will host a webcast call for the investment community

Read more
Pharmaceutical Company News 

Amgen and Kyowa Kirin to Jointly Develop and Commercialize KHK4083, a Phase 3-Ready, Potential First-In-Class Treatment for Atopic Dermatitis

June 1, 2021 Michael Crowe Amgen

Agreement Renews Successful Global Collaboration That led to Several Groundbreaking Therapies in Multiple Disease Areas KHK4083 Depletes OX40-Expressing T cells

Read more
Pharmaceutical Company News 

Amgen To Present At The 2021 Jefferies Healthcare Conference

May 28, 2021 Michael Crowe Amgen

THOUSAND OAKS, Calif., May 28, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) will present at the 2021 Jefferies Healthcare Conference at 1:30 p.m. ET

Read more
Pharmaceutical Company News 

FDA Approves LUMAKRAS™ (Sotorasib), The First And Only Targeted Treatment For Patients With KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer

May 28, 2021 Michael Crowe Amgen

THOUSAND OAKS, Calif., May 28, 2021 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration

Read more
Pharmaceutical Company News 

Amgen To Present AT the Cowen 2nd Annual Virtual Oncology Innovation Summit

May 19, 2021 Michael Crowe Amgen

THOUSAND OAKS, Calif., May 19, 2021 /PRNewswire/ — Amgen (NASDAQ: AMGN) will present at the Cowen 2nd Annual Virtual Oncology Innovation Summit

Read more
Pharmaceutical Company News 

Amgen To Showcase New Data From Oncology Portfolio At ASCO 2021

May 19, 2021 Michael Crowe Amgen

THOUSAND OAKS, Calif., May 19, 2021 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced that new data from its expanding oncology

Read more
Pharmaceutical Company News 

New Tezepelumab Data Continue To Strengthen Profile For A Broad Population Of Severe Asthma Patients

May 13, 2021 Michael Crowe Amgen

THOUSAND OAKS, Calif., May 13, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) and AstraZeneca today announced detailed results for tezepelumab, a potential

Read more
Pharmaceutical Company News 

Efficacy Of Repatha® (Evolocumab) Across High-Risk Patient Populations Reinforced At ACC.21

May 11, 2021 Michael Crowe Amgen

THOUSAND OAKS, Calif., May 11, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced the presentation of four cardiovascular research abstracts, including

Read more
Pharmaceutical Company News 

Amgen Announces Tezepelumab Biologics License Application Submitted To U.S. FDA

May 10, 2021 Michael Crowe Amgen

THOUSAND OAKS, Calif., May 10, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced its partner AstraZeneca (NASDAQ:AZN) submitted a Biologics License Application

Read more
Pharmaceutical Company News 

Amgen To Present At The 2021 Bank of America Merrill Lynch Healthcare Conference

May 6, 2021 Michael Crowe Amgen

THOUSAND OAKS, Calif., May 6, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) will present at the 2021 Bank of America Merrill Lynch Virtual Healthcare

Read more
Pharmaceutical Company News 

FDA Accepts Amgen’s Supplemental New Drug Application For Otezla® (apremilast) For Adults With Mild-To-Moderate Plaque Psoriasis

May 5, 2021 Michael Crowe Amgen

THOUSAND OAKS, Calif., May 5, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for

Read more
Pharmaceutical Company News 

Amgen Provides Updated Information On LUMAKRAS™ (Sotorasib)¹ Dose Comparison Study

April 28, 2021 Michael Crowe Amgen

THOUSAND OAKS, Calif., April 28, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that it agreed last night with the FDA’s proposed post-marketing requirement

Read more
Pharmaceutical Company News 

Amgen Reports First Quarter 2021 Financial Results

April 27, 2021 Michael Crowe Amgen

THOUSAND OAKS, Calif., April 27, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced financial results for the first quarter of 2021.

Read more
Pharmaceutical Company News 

OTEZLA® (apremilast) Significantly Improved Measures Of Disease Severity In Adults With Mild-To-Moderate Plaque Psoriasis

April 23, 2021 Michael Crowe Amgen

THOUSAND OAKS, Calif., April 23, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced Otezla® (apremilast) improved measures of disease severity in adults

Read more
Pharmaceutical Company News 

Amgen Announces Webcast Of 2021 First Quarter Financial Results

April 22, 2021 Michael Crowe Amgen

THOUSAND OAKS, Calif., April 22, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that it will report its first quarter financial results

Read more
Pharmaceutical Company News 

Amgen’s Investigational Targeted Treatment Bemarituzumab Granted Breakthrough Therapy Designation

April 19, 2021 Michael Crowe Amgen

THOUSAND OAKS, Calif., April 19, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) granted

Read more
Pharmaceutical Company News 

Amgen Launches Biomarker Assist™, a Program To Help More Patients With Non-Small Cell Lung Cancer Gain Access To Biomarker Testing

April 19, 2021 Michael Crowe Amgen

THOUSAND OAKS, Calif., April 19, 2021 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced the launch of Biomarker Assist™, a program

Read more
Pharmaceutical Company News 

Amgen Successfully Completes Acquisition Of Five Prime Therapeutics

April 16, 2021 Michael Crowe Amgen

THOUSAND OAKS, Calif., April 16, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that it has successfully completed its previously announced

Read more
Pharmaceutical Company News 

Amgen to Acquire Rodeo Therapeutics Corporation

March 30, 2021 Michael Crowe Amgen

THOUSAND OAKS, Calif. and SEATTLE, March 30, 2021 /PRNewswire/ — Amgen Inc. (NASDAQ:AMGN) and Rodeo Therapeutics Corporation (Rodeo) today announced an

Read more
Pharmaceutical Company News 

Amgen To Present At The Oppenheimer 31st Annual Healthcare Conference

March 11, 2021 Michael Crowe Amgen

THOUSAND OAKS, Calif., March 11, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) will present at the virtual Oppenheimer 31st Annual Healthcare Conference

Read more
Pharmaceutical Company News 

Amgen To Acquire Five Prime Therapeutics For $1.9 Billion in Cash

March 4, 2021 Michael Crowe Amgen

THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., March 4, 2021 /PRNewswire/ — Amgen (NASDAQ: AMGN) and Five Prime Therapeutics (NASDAQ:

Read more
Page 1 of 612345...»Last »

World Company Directory showcases the largest companies in the world – segmented by country and industry sector. The website is useful for anyone looking for new suppliers, acquisition targets, or to target new customers or to simply to view the profile of a company.

Visit World Company Directory


Top1000CompanyLists.com. Buy lists of Top 1000 companies ranked by revenue across thousands of industries and countries.

Visit Top 1000 Company Lists


Breaking Company News

  • Collé acquires Rema
  • Arabian Aerospace - Qatar Airways to launch new route to Lusaka and Harare
  • Infected traveller received one vaccine dose, 14 locations of interest
  • Boston Pizza adds BP’s Perfectly Plant-Based Burger with Lightlife and Hungry Herbivore Pizza with Field Roast Italian Sausage Crumble to its summertime menu – Maple Leaf Foods
  • CVC Capital Partners VIII to invest in ExamWorks
  • UK Government provides highest level of support for exporters in 30 years
  • White & Case Advises Banks on Sirius’ €400 Million Bond Issue | White & Case LLP
  • Welsh holiday park firm makes acquisition as staycation M&A surge continues
  • N.C. A&T Chancellor Reflects on Last Year, Highlights HBCUs’ Role in Driving Minority Student Advancement and Social Change
  • Duchêne finishes the wooden extension of a secondary school near Namur, just in time for the students’ first exams!
  • Q&A: Talking with Mary Magleby, Waste Management Project Manager
  • DriveTech and r2c team-up in driver training, risk and fleet management collaboration
  • WBD advises private equity firm LDC on investment in digital media company Hybrid
  • Bird & Bird advises WH Ireland Limited on the £15 million Pensana plc fundraise
  • Jim Beam® Launches Jim Beam® Orange, Offering a Juicy and Bright Twist to a Highball Cocktail
  • IBM Makes Resources Available to Small Business Owners At No Cost to Them
  • EQT Growth investerar i Mollie, en av Europas största betaltjänstleverantörer
  • Covid-19: Fiji records two deaths amid record 180 new cases
  • Barbican announces its music season for autumn 2021 | Barbican
  • BSI Joins (ISC)² Official Training Partner Program
  • Republic of Belarus Sanctions
  • Aramark and Mashgin Collaborate to Deliver Innovative Fan Experience to 2021 Travelers Championship
  • Delta accelerates hiring as customers return to travel
  • New Ways to Shop for Products You Love Across Our Apps - About Facebook
  • Samsung Hosts Virtual Event “Samsung Networks: Redefined”
  • Vicki Smith, Echoing Our Company Policy & Culture of Inclusion
  • Robertson Construction Northern appointed to deliver new life sciences innovation centre at Inverness Campus
  • Entrepreneurial aspirations hit four-year high as Canadians believe the pandemic has created new opportunities for small businesses: RBC Poll
  • Rackspace Technology Announces Enhanced Full-lifecycle Cloud Native Development Capabilities to Help Customers Build Modern Applications
  • Penningtons Manches Cooper named ‘HR Team of the Year’ at People in Law Awards 2021
  • Orkla ASA provides local pandemic assistance in India - Orkla.com
  • AT&T is Shutting Down its 3G Network: Here’s How to Prepare - TechBuzz by AT&T
  • Out of Many Come One: The Remarkable Flavor Storytelling of Chef Kwame Onwuachi
  • Alberto G. Musalem to Join Freddie Mac Board of Directors | Freddie Mac
  • EastEnders fans gobsmacked as Bobby and Dana ‘kiss’ despite Covid restrictions
  • AT&T Now Blocking or Labeling More Than 1 Billion Robocalls Per Month
  • Treat frozen chicken like it’s raw, warns FSA – Which? News
  • Ryan Lovatt’s Family Hope Inquest Will Provide Answers Following Corporal’s Death
  • Rise People reimagines the employee experience for the new future of work after COVID-19
  • BBPA predicts England fans to buy 3 million pints for Czech Republic match
  • Lockheed Martin Names New Leader for F-22 Program
  • Retail: Six months since Brexit – and 5 years since the referendum
  • XPO and Electrolux
  • White & Case Advises BearingPoint RegTech on Acquisition of Vizor Software | White & Case LLP
  • Jaguar Land Rover suppler in talks to avoid administration
  • Dominion Energy Virginia Customers to Benefit from a Stronger Grid, Expansion of Renewable Energy
  • Résirep sur la falaise de La Roche Blanche
  • BBC calls on public sector chefs to audition for new cooking series
  • Nippon Express (China) opens new office in Jinan, Shandong Province New location will offer forwarding services to the inland areas of Shandong Province
  • Q&A: Talking with Susana Gozalo, Portfolio Lead for Rail Major Projects

About

Company News HQ is a global business news portal. It is the leading industry news source for major companies across a number of industry verticals.

Links

  • Advertising
  • News Tracking Service
  • Submit News
  • Subscribe
  • Contact Us
Copyright © 2021 CompanyNewsHQ. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT
  • Industry
    ▼
    • Accountancy
    • Aerospace & Defense
    • Airline
    • Automotive
    • Chemicals
    • Construction
    • Energy
    • Facilities Management
    • Fashion
    • Finance and Utilities
    • Food and Drink
    • Insurance
    • Legal
    • Logistics
    • M&A News
    • Media & Entertainment
    • Medical Device
    • Parcels
    • Pharmaceutical
    • Private Equity
    • Retail
    • Technology
    • Telecoms
    • Travel
  • Companies A-Z
  • Submit A Press Release
  • Subscribe
  • Advertising
  • Market Reports
  • Contact Us